Ozempic cost without insurance in 2026
Where to actually get it
Featured affiliate partners; we may earn a commission, which never changes a score. Full spread in the table below.
Ozempic lists at $1027.51 a pen, and almost nobody paying cash needs to pay it. Novo Nordisk sells it directly for $199/mo through NovoCare Pharmacy, and the oral pill for $149/mo, with a prescription. Non-FDA-approved compounded semaglutide programs publish prices from $59/mo, about 17.4x below list, and is not FDA-approved.
The four ways to pay cash, cheapest first
| Route | Cash price | What you are actually buying |
|---|---|---|
| Compounded semaglutide | from $59/mo | Pharmacy-prepared product. Not FDA-approved; equivalence to Ozempic is not established. |
| NovoCare Pharmacy, oral pill | from $149/mo | Brand Ozempic, direct from Novo. Prescription required. |
| NovoCare Pharmacy, pen | from $199/mo | Brand Ozempic, direct from Novo. Price rises with dose. |
| Retail pharmacy, no discount | $1027.51 | The list price. Paying this is almost always avoidable. |
Manufacturer figures verified 2026-08-14 on Novo's own pharmacy page. We earn nothing from the NovoCare routes and list them first anyway, because they are cheaper than every brand-Ozempic price in our own index (the lowest of those is $149/mo).
Cheapest verified compounded semaglutide right now
Compounded semaglutide is the cheapest route, and the trade-off is regulatory rather than chemical: compounded semaglutide is not an FDA-approved finished product, so the agency does not review it for safety, effectiveness or quality. Every price below is one we re-checked ourselves, with the date on the provider's review page. Programs that bill the medication separately are excluded, because a membership fee is not comparable to an all-in price.
- 1Collective4.6/10 · from · price checked 2026-09-15from $59/moVisit
- 2Embody7.3/10 · from · price checked 2026-09-20from $69/moVisit
- 3Eden Health GLP-16.9/10 · month-to-month, from $34 on a plan · price checked 2026-08-28$99/moVisit
- 4Strut Health6.2/10 · from · price checked 2026-09-03from $99/moVisit
- 5SkinnyRx5.3/10 · first month, rises after · price checked 2026-09-03$99/moVisit
Sorted by verified price, not by who pays us. How we rank.
Why insurance denies Ozempic so often
Ozempic is approved for type 2 diabetes, not for weight loss. Wegovy is the semaglutide approval for chronic weight management. If a prescription is written for weight loss, an insurer reading the indication has a straightforward basis to deny it, and that denial is what sends most people to this page. If weight management is the goal, the on-label conversation is about Wegovy or compounded semaglutide, and the cash prices above apply either way.
Frequently Asked Questions
How much does Ozempic cost without insurance?
The list price is $1027.51 per pen, but almost nobody paying cash needs to pay it. Novo Nordisk sells Ozempic directly through NovoCare Pharmacy from $199/mo for the pen and $149/mo for the oral pill, with a prescription. Compounded semaglutide products are not FDA-approved, and their formulation, quality, and clinical equivalence to Ozempic are not established; published program prices start at $59/mo.
Is the $199 NovoCare price real?
Yes, and it is the manufacturer's own programme rather than a coupon site's estimate. It requires a prescription, the price varies by dose, and Novo lists government beneficiaries as excluded from some savings offers. We verified it on 2026-08-14 on Novo's own pharmacy page.
Is compounded semaglutide the same as Ozempic?
No. Ozempic is an FDA-approved finished product tested as a whole. A compounded semaglutide product is prepared for an individual patient and is not FDA-approved: the agency does not review it for safety, effectiveness, or quality before sale. Its formulation and clinical equivalence to Ozempic should not be assumed.
Does Ozempic cover weight loss?
Ozempic is approved for type 2 diabetes, not for weight loss. Wegovy is the semaglutide approval for chronic weight management. Prescribing Ozempic for weight loss alone is off-label, and insurers frequently deny it on that basis, which is part of why so many people end up paying cash.